Literature Highlights – May 2023

Comment on: Rapid Efficacy of Anifrolumab Across Multiple Subtypes of Recalcitrant Cutaneous Lupus Erythematosus Parallels Changes in Discrete Subsets of Blood Transcriptomic and Cellular Biomarkers Comment by: Professor Edward Vital, Associate Professor in Systemic Lupus Erythematosus at University of Leeds. Chair of BILAG and the Lupus Forum.   Anifrolumab has been shown to be effective … Read more

Comment on: Sustained glucocorticoids tapering into phase 3 trials of anifrolumab: a post hoc analysis of the tulip one and tulip two trials. Bruce IN, et al. Rheumatology (Oxford). 2023;62(4):1526–1534. Commented by: Professor Edward Vital, Associate Professor in Systemic Lupus Erythematosus at University of Leeds. Chair of BILAG and the Lupus Forum.   A number … Read more